RMTI stock forecast
Our latest prediction for Rockwell Medical, Inc.'s stock price was made on the June 30, 2020 when the stock price was at 1.95$.
In the short term (2weeks), RMTI's stock price should outperform the market by 1.07%. During that period the price should oscillate between -9.89% and +13.05%.
In the medium term (3months), RMTI's stock price should underperform the market by -3.30%. During that period the price should oscillate between -37.23% and +33.22%.Get email alerts
Create a solid portfolio with RMTI
About Rockwell Medical, Inc.
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Hackensack, NJ.
At the moment the company generates 62M USD in revenues.
On its last earning announcement, the company reported a loss of -0.53$ per share.
The book value per share is 0.33$
Three months stock forecastJune 30, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|